In Trading, Results Matter.
Our Top 10 exits in last 5 trading days.

Eiger Bio Pharmaceuticals, Inc.. Trade Record

NASDAQ:EIGR Eiger Bio Pharmaceuticals, Inc. stock gains 37.51% Exit Feb 8, 2019 a Trade Record by priceseries

Trade Chart
Trade Chart EIGR Dec 31, 2018, priceSeries
About Eiger Bio Pharmaceuticals, Inc.

Eiger BioPharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on providing various products for the treatment of orphan diseases in the United States. It portfolio of products include Sarasar, an indication for the hepatitis delta virus infection; Exendin, which is used for the treatment of hypoglycemia associated with bariatric surgery; and Bestatin that is used for the treatment of pulmonary arterial hypertension and lymphedema, which are under Phase II clinical trials. The company was founded in 2008 and is headquartered in Palo Alto, California.

Trade Information
Trade Type
Entry Date
Dec 31, 2018
Entry Price
Sell Date
Feb 8, 2019
Sell Price
Net Gain
Hold Time
27 Trading Days